Improving the “real life” management of schizophrenia spectrum disorders by LAI antipsychotics: A one-year mirror-image retrospective study in community mental health services
Authors:
Open Access
- 10 March 2020
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 15 (3) , e0230051
Abstract
Schizophrenia poses a significant economic burden on the healthcare system as well as it has a significant impact on society at large. Reasons for such a high economic burden of schizophrenia include the frequent relapses and hospitalizations occurring in this disorder. We analyze the effectiveness of long-acting injectable antipsychotics (LAIs) compared to oral medications, in terms of “clinical process management” in a sample of patients with a diagnosis of schizophrenia spectrum disorder treated in community mental health centers. An observational, retrospective, mirror-image study was carried out to evaluate the effectiveness of LAIs compared to oral medications in terms of number of hospitalizations, emergency visits and planned visits on a 10-year period (from July 2007 to June 2017). Differences between first and second generation LAIs were also explored. Our findings show that hospitalization and emergency visits are significantly decreased with the use of LAIs, while planned visits are increased in patients treated with LAIs. Our results suggest that LAIs, in particular, second generation ones, reduce hospitalization rates and emergency visits, improving the economic burden of schizophrenia. Therefore, LAIs should be considered a cost-effective treatment in the management of schizophrenia under routine conditions.Keywords
This publication has 19 references indexed in Scilit:
- How study designs influence comparative effectiveness outcomes: The case of oral versus long-acting injectable antipsychotic treatments for schizophreniaSchizophrenia Research, 2014
- This is why there is hope for psychiatryWorld Psychiatry, 2014
- Long-Acting Injectable Versus Oral Antipsychotics in SchizophreniaThe Journal of Clinical Psychiatry, 2013
- Shared understanding in psychiatrist–patient communication: Association with treatment adherence in schizophreniaPatient Education and Counseling, 2013
- Hospitalisation rates in patients switched from oral anti-psychotics to aripiprazole once-monthly for the management of schizophreniaJournal of Medical Economics, 2013
- Impact of Early Nonadherence to Oral Antipsychotics on Clinical and Economic Outcomes Among Patients with SchizophreniaAdvances in Therapy, 2013
- Long-Acting Injectable vs Oral Antipsychotics for Relapse Prevention in Schizophrenia: A Meta-Analysis of Randomized TrialsSchizophrenia Bulletin, 2012
- Maintenance treatment with antipsychotic drugs for schizophreniaCochrane Database of Systematic Reviews, 2012
- Predictors and clinical consequences of non-adherence with antipsychotic medication in the outpatient treatment of schizophreniaPsychiatry Research, 2010
- Attitudes Toward Antipsychotic MedicationArchives of General Psychiatry, 2005